Growing community of inventors

Southlake, TX, United States of America

Colin J Meyer

Average Co-Inventor Count = 2.00

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 204

Colin J MeyerGordon W Gribble (3 patents)Colin J MeyerMichael B Sporn (3 patents)Colin J MeyerTadashi Honda (3 patents)Colin J MeyerKaren T Liby (3 patents)Colin J MeyerRobert M Kral, Jr (3 patents)Colin J MeyerRobert M Kral (3 patents)Colin J MeyerKaren Liby (3 patents)Colin J MeyerMichael Sporn (3 patents)Colin J MeyerGordon W Gribble (3 patents)Colin J MeyerTadashi Honda (3 patents)Colin J MeyerJiang Zhang (2 patents)Colin J MeyerWarren Huff (2 patents)Colin J MeyerJiang Zhang (1 patent)Colin J MeyerWarren Huff (1 patent)Colin J MeyerKaren Liby (0 patent)Colin J MeyerColin J Meyer (9 patents)Gordon W GribbleGordon W Gribble (38 patents)Michael B SpornMichael B Sporn (29 patents)Tadashi HondaTadashi Honda (21 patents)Karen T LibyKaren T Liby (14 patents)Robert M Kral, JrRobert M Kral, Jr (10 patents)Robert M KralRobert M Kral (3 patents)Karen LibyKaren Liby (3 patents)Michael SpornMichael Sporn (3 patents)Gordon W GribbleGordon W Gribble (3 patents)Tadashi HondaTadashi Honda (3 patents)Jiang ZhangJiang Zhang (2 patents)Warren HuffWarren Huff (2 patents)Jiang ZhangJiang Zhang (5 patents)Warren HuffWarren Huff (1 patent)Karen LibyKaren Liby (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Reata Pharmaceuticals, Inc. (7 from 61 patents)

2. Dartmouth College (3 from 662 patents)

3. Reata Pharmaceuticals Holdings, LLC (2 from 7 patents)


9 patents:

1. 11911395 - Methods of treating obesity using antioxidant inflammation modulators

2. 11446313 - Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof

3. 10953020 - Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof

4. 10105372 - Methods of treating obesity using antioxidant inflammation modulators

5. 9757359 - Synthetic triterpenoids and methods of use in the treatment of disease

6. 9155721 - Delayed release, oral dosage compositions that contain amorphous CDDO-Me

7. 8747901 - Delayed release, oral dosage compositions that contain amorphous CDDO-Me

8. 8455544 - Synthetic triterpenoids and methods of use in the treatment of disease

9. 8129429 - Synthetic triterpenoids and methods of use in the treatment of disease

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…